FCOM 2024 – Oropharyngeal Cancer: Circulating Tumor Markers
This session focuses on the emerging role of circulating tumor HPV-DNA as a biomarker in the management of oropharyngeal cancer. Attendees will gain insights into the logistics of measuring circulating